Physician profile
David Steven Casper
NPI 1477971422
$195,297.17
in general payments reported to CMS, 2019-2025
14 companies · $44K in 2025
The $44K reported for 2025 was more than what 86% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,291 · 2020: $3,722 · 2021: $20K · 2022: $20K · 2023: $38K · 2024: $66K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $129K · Travel and Lodging: $11K · Food and Beverage: $5,724 · Education: $1,702 · Entertainment: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $129,300.00 |
| Travel and Lodging | $11,194.02 |
| Food and Beverage | $5,723.74 |
| Education | $1,701.68 |
| Entertainment | $151.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $88,079.59 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Stryker Corporation | $81,636.65 | 2019-2025 | Monterey Al, Everest Spinal System, Aero-Ll |
| Vb Spine LLC | $23,446.40 | 2025 | Yukon Oct Spinal System, Es2 Spinal System, Everest Spinal System |
| Nuvasive, INC. | $710.91 | 2022-2023 | Tlif |
| Globus Medical, INC. | $303.41 | 2019-2025 | Reline, Sable, Excelsius Gps |
| Kuros Biosciences USA, INC | $294.55 | 2024-2025 | Magnetos |
| Leo Pharma INC. | $235.20 | 2019-2021 | |
| Seaspine Orthopedics Corporation | $133.26 | 2021-2022 | |
| Zimvie INC. | $124.77 | 2023 | |
| Almirall LLC | $118.37 | 2019 | |
| Djo, LLC | $81.67 | 2019 | |
| Medtronic, INC. | $67.73 | 2021-2025 | Rapidvac, Infinity Occipitocervical Upper Thoracic System |
| Bioventus LLC | $64.66 | 2023 | Bonescalpel |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Casper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.